SRY-Box 13 (SOX13), a member of the Sry-related high-mobility group box (Sox) transcription factor family, was testified to participate in the progression of several tumors, such as glioma (He et al. 2019) and gastric carcinoma (Bie et al. 2019). Here, SOX13 is linked to central nervous system cancer.